title: Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis.
authors.affiliation: Department of Internal Medicine, University of Messina, A.O.U. Policlinico G. Martino Via C. Valeria, 98125, Messina, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Lasco
authors.forename: A
authors.initials: A
authors.lastname: Catalano
authors.forename: N
authors.initials: N
authors.lastname: Morabito
authors.forename: A
authors.initials: A
authors.lastname: Gaudio
authors.forename: G
authors.initials: G
authors.lastname: Basile
authors.forename: A
authors.initials: A
authors.lastname: Trifiletti
authors.forename: M
authors.initials: M
authors.lastname: Atteritano
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D050071:Bone Density Conservation Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000378:metabolism*; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000378:metabolism; D019379:Teriparatide / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D050071:Bone Density Conservation Agents; D019379:Teriparatide; D000324:Adrenocorticotropic Hormone; D002118:Calcium; D006854:Hydrocortisone